Ssumangarg@gmail - Com 20220825193722

Laboratory Investigation Report
Patient Name : Mrs. Suman Centre : 2628 - Manav Medicare Centre

Age/Gender : 36 Y 0 M 0 D /F OP/IP No :/
Max ID/Mobile : ML02244569/9987813665 Collection Date/Time : 25/Aug/2022 11:31AM
Lab ID : 2383082200051 Receiving Date : 25/Aug/2022
Ref Doctor : Dr.V K Aggarwal Reporting Date : 25/Aug/2022
Passport No. :
Hematology
Wellwise Total Profile
Complete Haemogram, Peripheral Smear and ESR,EDTA

Date 25/Aug/2022 Unit Bio Ref
11:31AM Interval
Haemoglobin 12.1 g/dl 12.0 - 15.0
Packed Cell, Volume 37.5 % 36-46
Calculated
Total Leucocyte Count 10.8 10~9/L 4.0-10.0
(TLC)
Electrical Impedance
RBC Count 4.36 10~12/L 3.8-4.8
MCV 86.1 fL 83-101
MCH 27.8 pg 27-32
Calculated
MCHC 32.3 g/dl 31.5-34.5
Calculated
Platelet Count 323 10~9/L 150-410
MPV 10.6 fl 7.8-11.2
Calculated
RDW 14.2 % 11.5-14.5
Calculated
Differential Cell Count

VCS / Light Microscopy
Neutrophils 56.5 % 40-80

Lymphocytes 34.5 % 20-40
Monocytes 6.9 % 2-10
Eosinophils 1.3 % 1-6
Basophils 0.8 % 0-2
Absolute Leukocyte Count

Calculated from TLC & DLC
Absolute Neutrophil Count 6.1 10~9/L 2.0-7.0

Absolute Lymphocyte 3.7 10~9/L 1.0-3.0
Count
Absolute Monocyte Count 0.75 10~9/L 0.2-1.0
Absolute Eosinophil Count 0.14 10~9/L 0.02-0.5
Absolute Basophil Count 0.09 10~9/L 0.02-0.1
ESR (Westergren) 50 mm/hr <=12
Page 1 of 13
SIN No:B2B1647910, Test Performed at :910 - Max Hospital - Saket M S S H, Press Enclave Road, Mandir Marg, Saket, New Delhi, Delhi
110017
Booking Centre :2628 - MANAV MEDICARE CENTRE, E-11,SOUTH EXTENSION PART-1 NEW DELHI-110049, 9810039677
The authenticity of the report can be verified by scanning the Q R Code on top of the page

Passport No. :
Hematology
Peripheral Smear
Examination
RBC: - Normocytic Normochromic
WBC: - Counts Mild Increased.
Platelet: - Adequate
Impression: - Mild Leukocytosis.
Kindly correlate with clinical findings
*** End Of Report ***
Page 2 of 13
110017

Passport No. :
Clinical Biochemistry
Fasting Blood Sugar (Glucose) , (FBS), Fluoride Plasma

Date 25/Aug/2022 Unit Bio Ref Interval
11:31AM
Glucose (Fasting) 85 mg/dL 74 - 99
Hexokinase
HbA1c (Glycated/ Glycosylated Hemoglobin) Test

HPLC

11:31AM Interval
Glycosylated 5.6 % < 5.7
Haemoglobin(Hb A1c)
Glycosylated 38.02 mmol/mol < 39.0
Haemoglobin(Hb A1c)
IFCC
Average Glucose Value 114.88 mg/dL
For the Last 3 Months
Average Glucose Value 6.36 mmol/L
For the Last 3 Months
IFCC
Interpretation The following HbA1c ranges recommended by the American Diabetes Assocation(ADA) may be used as an aid in the diagnosis of diabetes
mellitus.
HbA1C(NGSP %) HbA1C(IFCC mmol/mol) Suggested Diagnosis

> 6.5 > 48 Diabetic
5.7 - 6.4 39 - 47 Pre- Diabetic
< 5.7 < 39 Non - Diabetic
HbA1C provides a useful index of average glycaemia over the preceding 6-8 weeks.
It is suggested that HbA1c is measured every 6 months in stable patients, every 3 months in patients with unstable metabolic control and every month in
pregnancy.
Increased Glycated hemoglobin is a reflection of Hyperglycemia.
Page 3 of 13
110017

Passport No. :
Page 4 of 13
110017

Passport No. :
Immunoassay
Thyroid Profile*,Serum*
11:31AM Interval
Free Triiodothyronine 3.28 pg/mL 2.6 - 4.2
(FT3)
CLIA
Free Thyroxine (FT4) 0.87 ng/dL 0.58 - 1.64
CLIA
Thyroid Stimulating 2.99 µIU/mL 0.34 - 5.6
Hormone
CLIA
Comment
Premature Cord Blood
Upto 2 1st 2nd 3rd
Parameter Unit (28 - 36 (> 37 Adult
Month Trimester Trimester Trimester
weeks) weeks)
FT3 Pg/mL 0.15 - 3.91 2.4 - 5.6 2.6 - 4.2 2.11 - 3.83 1.96 - 3.38 1.96 - 3.38
TSH uIU/ml 0.7 - 27.0 2.3 - 13.2 0.5 - 10 0.38 - 5.33 0.1 - 2.5 0.2 - 3.0 0.3 - 3.0
Note : TSH levels are subject to circadian variation, reaching peak levels between 2 – 4 am
and at a minimum between 6 – 10 pm. The variation is of the order of 50% - 206 %, hence
time of the day has influence on the measured serum TSH concentrations.
Page 5 of 13
110017

Passport No. :
Kidney Function Test (KFT) Profile with Calcium, Uric Acid*, Serum
11:31AM Interval
Urea 21.3 mg/dL 17.0 - 43.0
Urease, UV
Blood Urea Nitrogen 9.95 mg/dL 7.9 - 20.0
Calculated
Creatinine 0.7 mg/dl 0.61 - 1.24
Rate-Jaffe
eGFR 94.68 ml/min/1.73
MDRD m²
Bun/Creatinine Ratio 14.21 Ratio 12:1 - 20:1
Calculated
Uric Acid 3.4 mg/dL 2.6 - 6.0
Uricase, Colorimetric
Calcium (Total) 9.8 mg/dL 8.8 - 10.6
Arsenazo III
Sodium 139.0 mmol/L 136 - 146
ISE Indirect
Potassium 4.55 mmol/L 3.5 - 5.1
ISE indirect
Chloride 104.0 mmol/L 101 - 109
ISE indirect
Bicarbonate 18.0 mmol/L 21 - 31
Colorimetric, PEPC
Interpretation Ref. Range

eGFR - Estimated Glomerular Filteration Rate is calculated by MDRD equation which is most accurate for GFRs ≤ 60ml / min /1.73 m².MDRD equation is used
for adult population only.
<60ml / min / 1.73 m² - Chronic Kidney Disease
<15 ml / min /1.73 m² - Kidney failure
BUN/Creatinine Ratio :-
Increased in reduced renal perfusion (e.g. dehydration, Hypovolemic shock, Congestive Heart Failure) or Obstructive uropathy. Decreased in Acute Renal Tubular
necrosis.
Page 6 of 13
110017

Passport No. :
Liver Function Test (LFT), Serum

11:31AM
Total Protein 7.20 g/dL 6.6 - 8.3
Biuret
Albumin 4.1 g/dL 3.5 - 5.2
Bromcresol Green (BCG)
Globulin 3.1 g/dl 2.3 - 3.5
Calculated
A.G. ratio 1.3 1.2 - 1.5
Calculated
Bilirubin (Total) 0.4 mg/dL 0.3 - 1.2
DPD
Bilirubin (Direct) 0.08 mg/dL 0.0 - 0.2
Diazotization
Bilirubin (Indirect) 0.32 mg/dL 0.1 - 1.0
Calculated
SGOT- Aspartate 20 U/L < 50
Transaminase (AST)
UV without P5P
SGPT- Alanine 18 IU/L < 35
Transaminase (ALT)
UV without P5P
AST/ALT Ratio 1.11 Ratio
Calculated
Alkaline Phosphatase 89 IU/L 30 - 120
PNPP, AMP Buffer
GGTP (Gamma GT), 63.0 IU/L < 38
Serum
Enzymatic Rate
Interpretation AST/ALT Ratio : -

In Case of deranged AST and/or ALT, the AST/ALT ratio is < 2.0 in alcoholic liver damage and > 2.0 in non – alcoholic liver damage
Page 7 of 13
110017

Passport No. :
Lipid Profile,Serum
11:31AM Interval
Cholesterol 219 mg/dL < 200
Cholesterol oxidase, esterase,
peroxidase
HDL Cholesterol 53.0 mg/dL > 40
Direct measure, immunoinhibition
LDL Cholesterol 137.0 mg/dL < 100
Direct measure
Triglyceride 105.0 mg/dL < 150
Enzymatic, end point
VLDL Cholesterol 21.0 mg/dl < 30
Calculated
Total Cholesterol/HDL 4.1 .. 0.0-4.9
Ratio
Calculated
Non-HDL Cholesterol 166.00 mg/dL < 130
Calculated
HDL/LDL 0.39 Ratio 0.3 - 0.4
Calculated
Interpretation
Optimal: < 100 mg/dL

Near Optimal/ Above Optimal: 100-
Desirable: < 200 mg/dL
129
Borderline High: 200-239
Total mg/dL
mg/dL LDL-C
Cholesterol Borderline High: 130-159 mg/dL
High ≥ 240 mg/dL
High: 160-189 mg/dL
Very High: ≥ 190 mg/dL
Normal: <150 mg/dL

Low HDL: < 40 mg/dL Borderline High: 150-199 mg/dL
HDL-C Triglyceride
High HDL: ≥ 60 mg/dL High: 200-499 mg/dL
Very High: ≥ 500 mg/dL
Page 8 of 13
110017

Passport No. :
Inorganic Phosphorus, Serum

11:31AM Interval
Phosphorus(inorg) 4.0 mg/dL 2.5 - 4.5
Phosphomolybdate-UV
Interpretation
Increased in Osteolytic metastatic bone tumors, myelogenous leukemia, sarcoidosis, milk-alkali syndrome, vitamin D intoxcation, healing fractures, renal failure,
hyperparathyroidism, PTH resistance (Pseudohypoparathyroidism) and diabetes mellitus with ketosis.
Decreased in Osteomalacia, steatorrhea, renal tubular acidosis, growth hormone deficiency, acute alcoholism, gram-negative bacterial septicemia, hypokalemia,
familial hypophosphatemic rickets, Vitamin D deficiency, severe malnutrition, malabsorption, secondary diarrhea, vomiting, nasogastric suction, primary
hyperthyroidism and PTH producing tumors.
Page 9 of 13
110017

Passport No. :
Immunoassay
Vitamin D, 25 - Hydroxy Test (Vit. D3), Serum

11:31AM Interval
25 Hydroxy, Vitamin D 40.68 ng/mL 30-100
CLIA
Ref Range
25 (OH) Vitamin D Concentration Range
Vitamin D Status
(ng/ml)
Sufficiency 30-100
Insufficiency 20-29
Deficiency <20
Potential Toxicity
>100
Interpretation
Vitamin D toxicity can be due to
1. Use of high doses of vitamin D for prophylaxis or treatment
2. Taking vitamin D supplements with existing health problems such as kidney disease, liver disease , tuberculosis and hyperparathyroidism
Vitamin D deficiency can be due to:
1. Inadequate exposure to sunlight,
2. Diet deficient in vitamin D
3. Malabsorption
Advice: Serum calcium, phosphorus and PTH
Page 10 of 13
110017

Passport No. :
Immunoassay
Vitamin B12 (Vit- B12), (Cyanocobalamin), Serum

11:31AM
Vitamin B12 341.0 pg/mL 120 - 914
CLIA
Interpretation
Note:- Vitamin B12 (Cobalamin)
Vitamin B12 is tested for patients with GIT disease, Neurological disease, psychiatric disturbances, malnutrition, alcohol abuse.
Increased in chronic renal failure, severe CHF.
Decreased in megaloblastic anemia.
Advise: CBC, peripheral smear, serum folate levels, intrinsic factor antibodies (IFA), bone marrow examination, if Vit B12 deficient.
Page 11 of 13
110017

Passport No. :
Clinical Pathology
Urine Routine And Microscopy

11:31AM
Macroscopy
Colour Pale Yellow Pale Yellow

Visual Observation/ Automated
PH 6.0 .. 5-6
Double Indicator
Specific Gravity 1.020 1.015 - 1.025
pKa change
Protein Neg Nil
Protein-error of indicators
Glucose. Neg Nil
Enzyme Reaction
Ketones Neg Nil
Acetoacetic Reaction
Blood Neg Nil
Benzidine Reaction
Bilirubin Neg Nil
Diazo Reaction
Urobilinogen Normal Normal
Ehrlichs Reaction
Nitrite Neg
Conversion of Nitrate
Microscopy
Red Blood Cells (RBC) 1 /HPF Nil

Light Microscopy/Image capture
microscopy
White Blood Cells 0 /HPF 0.0-5.0
microscopy
Squamous Epithelial Cells 3 /HPF
microscopy
Cast Nil /LPF Nil
microscopy
Crystals Nil .. Nil
microscopy
Bacteria Nil /HPF Nil
Page 12 of 13
110017

Passport No. :
Clinical Pathology

microscopy

Page 13 of 13
110017

Ssumangarg@gmail - Com 20220825193722

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Ssumangarg@gmail - Com 20220825193722

Uploaded by

Copyright:

Available Formats

Laboratory Investigation Report

Patient Name : Mrs. Suman Centre : 2628 - Manav Medicare Centre

Complete Haemogram, Peripheral Smear and ESR,EDTA

Differential Cell Count

Neutrophils 56.5 % 40-80

Absolute Leukocyte Count

Absolute Neutrophil Count 6.1 10~9/L 2.0-7.0

Patient Name : Mrs. Suman Centre : 2628 - Manav Medicare Centre

Impression: - Mild Leukocytosis.

Kindly correlate with clinical findings

*** End Of Report ***

Patient Name : Mrs. Suman Centre : 2628 - Manav Medicare Centre

Fasting Blood Sugar (Glucose) , (FBS), Fluoride Plasma

HbA1c (Glycated/ Glycosylated Hemoglobin) Test

Date 25/Aug/2022 Unit Bio Ref

HbA1C(NGSP %) HbA1C(IFCC mmol/mol) Suggested Diagnosis

Patient Name : Mrs. Suman Centre : 2628 - Manav Medicare Centre

Kindly correlate with clinical findings

*** End Of Report ***

Patient Name : Mrs. Suman Centre : 2628 - Manav Medicare Centre

Kindly correlate with clinical findings

*** End Of Report ***

Patient Name : Mrs. Suman Centre : 2628 - Manav Medicare Centre

Interpretation Ref. Range

Patient Name : Mrs. Suman Centre : 2628 - Manav Medicare Centre

Liver Function Test (LFT), Serum

Interpretation AST/ALT Ratio : -

Patient Name : Mrs. Suman Centre : 2628 - Manav Medicare Centre

Optimal: < 100 mg/dL

Normal: <150 mg/dL

Patient Name : Mrs. Suman Centre : 2628 - Manav Medicare Centre

Inorganic Phosphorus, Serum

Kindly correlate with clinical findings

*** End Of Report ***

Patient Name : Mrs. Suman Centre : 2628 - Manav Medicare Centre

Vitamin D, 25 - Hydroxy Test (Vit. D3), Serum

Patient Name : Mrs. Suman Centre : 2628 - Manav Medicare Centre

Vitamin B12 (Vit- B12), (Cyanocobalamin), Serum

Kindly correlate with clinical findings

*** End Of Report ***

Patient Name : Mrs. Suman Centre : 2628 - Manav Medicare Centre

Urine Routine And Microscopy

Colour Pale Yellow Pale Yellow

Red Blood Cells (RBC) 1 /HPF Nil

Patient Name : Mrs. Suman Centre : 2628 - Manav Medicare Centre

Light Microscopy/Image capture

Kindly correlate with clinical findings

You might also like

* End Of Report *

* End Of Report *

* End Of Report *

* End Of Report *

* End Of Report *